• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    5/10/23 12:59:08 PM ET
    $ABNB
    $ADV
    $ADXN
    $ALTO
    Diversified Commercial Services
    Consumer Discretionary
    Real Estate
    Real Estate
    Get the next $ABNB alert in real time by email

    Gainers

    • Unique Fabricating, Inc. (NYSE:UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday.
    • Harbor Custom Development, Inc. (NASDAQ:HCDI) gained 172% to $12.99 after the company announced a buyer waived all contingencies on a $14,250,000 sale of townhomes.
    • CTI BioPharma Corp. (NASDAQ:CTIC) jumped 84.9% to $8.91 after Swedish Orphan Biovitrum AB announced plans to acquire CTI BioPharma in a transaction worth $1.7 billion.
    • Microvast Holdings, Inc. (NASDAQ:MVST) rose 42% to $1.8633 after the company reported better-than-expected Q1 sales results.
    • Chanson International Holding (NASDAQ:CHSN) gained 41% to $2.22 after the company announced fiscal year 2022 financial results.
    • LivePerson, Inc. (NASDAQ:LPSN) jumped 33% to $5.79 after the company reported better-than-expected sales results.
    • Compass, Inc. (NYSE:COMP) rose 31% to $3.6850 after the company reported better-than-expected Q1 financial results and issued guidance.
    • Xometry, Inc. (NASDAQ:XMTR) jumped 30% to $17.40 after the company reported better-than-expected Q1 adjusted EPS and sales results.
    • Upstart Holdings, Inc. (NASDAQ:UPST) rose 29.8% to $18.30 after the company reported better-than-expected Q1 EPS and issued strong Q2 guidance.
    • Cano Health, Inc. (NYSE:CANO) gained 29% to $1.3550 after the company reported better-than-expected Q1 EPS and sales results.
    • Benson Hill, Inc. (NASDAQ:BHIL) rose 28.6% to $1.5821 after the company reported a year-over-year increase in
    • Q1 EPS results and reported better-than-expected Q1 sales results.
    • Angi Inc. (NASDAQ:ANGI) gained 27.6% to $3.19 after the company reported better-than-expected Q1 EPS and sales results.
    • GrowGeneration Corp. (NASDAQ:GRWG) rose 27.5% to $4.72 after the company reported better-than-expected Q1 EPS and sales results.
    • Vyant Bio, Inc. (NASDAQ:VYNT) gained 27% to $0.3690.
    • Upstart Holdings, Inc. (NASDAQ:UPST) surged 26.6% to $17.85 after the company reported better-than-expected Q1 EPS and issued strong Q2 guidance.
    • Open Lending Corporation (NASDAQ:LPRO) gained 24% to $9.39 after the company reported better-than-expected Q1 EPS results.
    • LegalZoom.com, Inc. (NASDAQ:LZ) gained 23.5% to $10.29 after the company reported better-than-expected Q1 adjusted EPS and sales results. Additionally, the company issued Q2 revenue guidance above analyst estimates.
    • Versus Systems Inc. (NASDAQ:VS) climbed 23% to $0.7792 after the company announced it secured a new patent for machine learning and artificial intelligence systems.
    • Celsius Holdings, Inc. (NASDAQ:CELH) rose 21.6% to $130.27 after the company reported better-than-expected Q1 sales results.
    • Sharps Technology, Inc. (NASDAQ:STSS) gained 21.2% to $1.18 after jumping 21% on Tuesday.
    • Taboola.com Ltd. (NASDAQ:TBLA) jumped 20% to $2.7450 after the company reported better-than-expected Q1 sales results, issued guidance and announced a buyback of up to $40 million.
    • Audacy, Inc. (NYSE:AUD) gained 20% to $0.1386 following strong quarterly sales.
    • Alto Ingredients, Inc. (NASDAQ:ALTO) gained 18.2% to $1.8550. Alto Ingredients recently reported better-than-expected Q1 sales.
    • Treasure Global Inc. (NASDAQ:TGL) jumped 18% to $1.77. Treasure Global integrated chatbot feature into ZCITY app, powered by its AI data analysis engine and ChatGPT.
    • MasterBrand, Inc. (NYSE:MBC) gained 17.4% to $10.15 after the company reported better-than-expected Q1 adjusted EPS and sales results.
    • Nextdoor Holdings, Inc. (NASDAQ:KIND) rose 17.3% to $2.4050 after the company reported better-than-expected Q1 sales results.
    • Lottery.com Inc. (NASDAQ:LTRY) rose 17% to $0.55.
    • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) shares climbed 16.8% to $0.9845.
    • CarGurus, Inc. (NASDAQ:CARG) gained 16.5% to $19.08.
    • Eventbrite, Inc. (NYSE:EB) climbed 15.8% to $7.34 after the company reported better-than-expected Q1 EPS and sales results.
    • MannKind Corporation (NASDAQ:MNKD) gained 15.5% to $4.39 after the company reported better-than-expected Q1 EPS and sales results.
    • Advantage Solutions Inc. (NASDAQ:ADV) surged 14.5% to $1.4885 following upbeat quarterly sales.
    • Wolverine World Wide, Inc. (NYSE:WWW) gained 14.2% to $17.24 following its Street-beating first-quarter results.
    • Addex Therapeutics Ltd (NASDAQ:ADXN) rose 13.4% to $0.8466 after the company announced the ADX71149 Phase 2 epilepsy clinical study has been recommended to continue by an Independent Interim Review Committee.
    • IAC Inc. (NASDAQ:IAC) gained 13.4% to $60.89 after the company reported better-than-expected Q1 results.
    • ZeroFox Holdings, Inc. (NASDAQ:ZFOX) gained 7.3% to $0.8350 after the company announced generative AI capabilities and previewed FoxGPT.

    Losers

    • Babylon Holdings Limited (NYSE:BBLN) fell 67% to $2.33 after posting downbeat quarterly sales.
    • Mobiquity Technologies, Inc. (NASDAQ:MOBQ) fell 32.4% to $0.1822 after surging 75% on Tuesday.
    • SeaStar Medical Holding Corporation (NASDAQ:ICU) dipped 31.5% to $1.32 after the company issued regulatory update related to its HDE application for pediatric selective cytopheretic device.
    • Shengfeng Development Limited (NASDAQ:SFWL) fell 30% to $6.12 after jumping around 99% on Tuesday.
    • Mesa Air Group, Inc. (NASDAQ:MESA) fell 25.3% to $1.5387 after the company reported worse-than-expected Q2 adjusted EPS and sales results.
    • Rail Vision Ltd. (NASDAQ:RVSN) fell 23.4% to $0.688 after the company priced a 3.94 million share registered direct offering at $0.84 per share.
    • Cytek Biosciences, Inc. (NASDAQ:CTKB) dipped 22.5% to $9.05 after the company reported worse-than-expected Q1 sales results.
    • ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) fell 20.6% to $4.0850. The FDA released briefing documents ahead of the advisory committee for ARS Pharmaceuticals Inc's neffy (ARS-1) for the emergency treatment of allergic reactions (type I), including anaphylaxis in adults and children.
    • ProAssurance Corporation (NYSE:PRA) dropped 20.4% to $15.00 after the company reported worse-than-expected Q1 adjusted EPS and sales results.
    • Reata Pharmaceuticals, Inc. (NASDAQ:RETA) fell 19.7% to $84.52 after the company reported Q1 financial results.
    • OKYO Pharma Limited (NASDAQ:OKYO) fell 19.6% to $1.56.
    • Semantix, Inc. (NASDAQ:STIX) fell 19% to $3.47.
    • Rayonier Advanced Materials Inc. (NYSE:RYAM) declined 19% to $4.44 after the company reported worse-than-expected Q1 adjusted EPS results.
    • Icahn Enterprises L.P. (NASDAQ:IEP) fell 18% to $31.12 after the company disclosed it was contacted by the U.S. Attorney's office for the Southern District of New York regarding information on its corporate governance. The company also reported a decrease in Q1 EPS.
    • Cuentas Inc. (NASDAQ:CUEN) shares dropped 17.5% to $5.70 after climbing around 27% on Tuesday.
    • MBIA Inc. (NYSE:MBI) fell 17.3% to $7.78 after the company reported Q1 financial results.
    • Silk Road Medical, Inc (NASDAQ:SILK) declined 17.3% to $34.60 after the company reported worse-than-expected Q1 EPS and sales results.
    • Twilio Inc. (NYSE:TWLO) fell 16.8% to $46.62 after the company issued weak Q2 revenue guidance.
    • WeTrade Group, Inc. (NASDAQ:WETG) fell 16% to $0.05 after declining 3% on Tuesday.
    • Axon Enterprise, Inc. (NASDAQ:AXON) dropped 15% to $192.60 despite better-than-expected Q1 results.
    • Cricut, Inc. (NASDAQ:CRCT) fell 13% to $8.72 after the company reported worse-than-expected Q1 sales.
    • Bluejay Diagnostics, Inc. (NASDAQ:BJDX) shares fell 12.2% to $0.25 after declining over 3% on Tuesday.
    • Amplitude, Inc. (NASDAQ:AMPL) shares dropped 10.4% to $10.42 following Q1 results.
    • Airbnb, Inc. (NASDAQ:ABNB) dropped 10.3% to $113.95 after the company issued soft Q2 guidance.
    • Invitae Corporation (NYSE:NVTA) fell 8.5% to $1.4750 after posting Q1 results.
    • Coherent Corp. (NYSE:COHR) dropped 6.8% to $29.77 following downbeat quarterly results.

    Now Read This: Bitcoin Surpasses $28,000 Following Inflation Data; Kava, Terra Classic Among Top Gainers

    Get the next $ABNB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABNB
    $ADV
    $ADXN
    $ALTO

    CompanyDatePrice TargetRatingAnalyst
    Upstart Holdings Inc.
    $UPST
    3/16/2026$43.00Neutral → Buy
    BTIG Research
    LegalZoom.com Inc.
    $LZ
    3/4/2026$6.00Equal Weight → Underweight
    Barclays
    Twilio Inc.
    $TWLO
    3/2/2026Hold → Buy
    TD Cowen
    MannKind Corporation
    $MNKD
    2/27/2026$3.50Outperform → Sector Perform
    RBC Capital Mkts
    Celsius Holdings Inc.
    $CELH
    2/27/2026$65.00Underperform → Buy
    BofA Securities
    Wolverine World Wide Inc.
    $WWW
    2/27/2026$18.00 → $22.00Market Perform
    Telsey Advisory Group
    OKYO Pharma Limited
    $OKYO
    2/20/2026$7.00Overweight
    Piper Sandler
    Upstart Holdings Inc.
    $UPST
    2/17/2026$30.00Sell → Neutral
    Compass Point
    More analyst ratings

    $ABNB
    $ADV
    $ADXN
    $ALTO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GrowGeneration Reports Fourth Quarter and Full Year 2025 Financial Results

    Full Year Net Sales of $161.7 million including Proprietary Brand Sales of $44.0 million Full Year Proprietary Brand Penetration Increased to 32.8% up from 24.2% in the prior year Full Year GAAP Net Loss Improved by $25.5 million; Adjusted EBITDA Improved by $8.5 million $46.1 million of Cash and Marketable Securities and no debt Board Authorizes $10 Million Share Repurchase Program 2026 Outlook: Revenue of $162 million to $168 million and Breakeven Adjusted EBITDA(1) DENVER, March 19, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ:GRWG), ("GrowGeneration," "GrowGen" or the "Company"), one of the nation's largest suppliers of specialty products for controlled envir

    3/19/26 4:05:00 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    OKYO Pharma Announces Chairman and Founder Acquires Shares

    LONDON and NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced it has been informed that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman, has a beneficial interest, has acquired 10,119 of the Company's ordinary shares on NASDAQ at $1.59, bringing his total holding to 10,526,416 shares. About Urcosimod (formerly called OK-101) Urcosimod is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor which is typically

    3/19/26 12:00:00 PM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Microvast and Iveco Group Cement Longstanding Partnership, Announce Next-Generation Battery Technology

    STAFFORD, Texas, March 19, 2026 (GLOBE NEWSWIRE) -- Microvast Holdings, Inc. (NASDAQ:MVST) ("Microvast", the "Company" or "we") and Iveco Group N.V. (MIL: IVG) ("Iveco Group") today reaffirm and expand their long-standing partnership, which has been advancing electric battery solutions across Europe. Since 2017, the collaboration has been delivering on the promise of sustainable transportation. Together, the companies have delivered cutting-edge battery technologies that power sustainable transportation and support the transition toward electrified fleets. The collaboration began with the IVECO eDaily project, where Microvast supplied battery systems based on VDA modules and 52Ah cells. T

    3/19/26 12:00:00 PM ET
    $MVST
    Industrial Machinery/Components
    Miscellaneous

    $ABNB
    $ADV
    $ADXN
    $ALTO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kilts James M bought $11,725 worth of shares (16,759 units at $0.70), increasing direct ownership by 1% to 1,532,106 units (SEC Form 4)

    4 - Advantage Solutions Inc. (0001776661) (Issuer)

    3/13/26 4:30:05 PM ET
    $ADV
    Real Estate

    Chief Executive Officer Castagna Michael bought $259,000 worth of shares (100,000 units at $2.59), increasing direct ownership by 4% to 2,575,911 units (SEC Form 4)

    4 - MANNKIND CORP (0000899460) (Issuer)

    3/10/26 9:30:02 PM ET
    $MNKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Growe Christopher bought $30,240 worth of shares (50,000 units at $0.60) (SEC Form 4)

    4 - Advantage Solutions Inc. (0001776661) (Issuer)

    3/10/26 4:30:07 PM ET
    $ADV
    Real Estate

    $ABNB
    $ADV
    $ADXN
    $ALTO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Upstart upgraded by BTIG Research with a new price target

    BTIG Research upgraded Upstart from Neutral to Buy and set a new price target of $43.00

    3/16/26 8:34:06 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    LegalZoom.com downgraded by Barclays with a new price target

    Barclays downgraded LegalZoom.com from Equal Weight to Underweight and set a new price target of $6.00

    3/4/26 8:35:56 AM ET
    $LZ
    EDP Services
    Technology

    Twilio upgraded by TD Cowen

    TD Cowen upgraded Twilio from Hold to Buy

    3/2/26 8:29:57 AM ET
    $TWLO
    Computer Software: Prepackaged Software
    Technology

    $ABNB
    $ADV
    $ADXN
    $ALTO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for SKYCLARYS issued to REATA PHARMACEUTICALS INC

    Submission status for REATA PHARMACEUTICALS INC's drug SKYCLARYS (ORIG-1) with active ingredient OMAVELOXOLONE has changed to 'Approval' on 02/28/2023. Application Category: NDA, Application Number: 216718, Application Classification: Type 1 - New Molecular Entity

    2/28/23 5:14:09 PM ET
    $RETA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABNB
    $ADV
    $ADXN
    $ALTO
    SEC Filings

    View All

    GrowGeneration Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - GrowGeneration Corp. (0001604868) (Filer)

    3/19/26 4:07:45 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    SEC Form 6-K filed by OKYO Pharma Limited

    6-K - OKYO Pharma Ltd (0001849296) (Filer)

    3/19/26 12:00:01 PM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 6-K filed by OKYO Pharma Limited

    6-K - OKYO Pharma Ltd (0001849296) (Filer)

    3/19/26 10:00:15 AM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABNB
    $ADV
    $ADXN
    $ALTO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Benton Todd E

    4 - Alto Ingredients, Inc. (0000778164) (Issuer)

    3/19/26 4:53:34 PM ET
    $ALTO
    Major Chemicals
    Industrials

    SEC Form 4 filed by Sneed James R

    4 - Alto Ingredients, Inc. (0000778164) (Issuer)

    3/19/26 4:52:48 PM ET
    $ALTO
    Major Chemicals
    Industrials

    SEC Form 4 filed by Olander Robert R.

    4 - Alto Ingredients, Inc. (0000778164) (Issuer)

    3/19/26 4:50:45 PM ET
    $ALTO
    Major Chemicals
    Industrials

    $ABNB
    $ADV
    $ADXN
    $ALTO
    Financials

    Live finance-specific insights

    View All

    GrowGeneration Reports Fourth Quarter and Full Year 2025 Financial Results

    Full Year Net Sales of $161.7 million including Proprietary Brand Sales of $44.0 million Full Year Proprietary Brand Penetration Increased to 32.8% up from 24.2% in the prior year Full Year GAAP Net Loss Improved by $25.5 million; Adjusted EBITDA Improved by $8.5 million $46.1 million of Cash and Marketable Securities and no debt Board Authorizes $10 Million Share Repurchase Program 2026 Outlook: Revenue of $162 million to $168 million and Breakeven Adjusted EBITDA(1) DENVER, March 19, 2026 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ:GRWG), ("GrowGeneration," "GrowGen" or the "Company"), one of the nation's largest suppliers of specialty products for controlled envir

    3/19/26 4:05:00 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    OKYO Pharma Announces Chairman and Founder Acquires Shares

    LONDON and NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced it has been informed that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman, has a beneficial interest, has acquired 10,119 of the Company's ordinary shares on NASDAQ at $1.59, bringing his total holding to 10,526,416 shares. About Urcosimod (formerly called OK-101) Urcosimod is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor which is typically

    3/19/26 12:00:00 PM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    OKYO Pharma Announces Director Acquires Shares

    LONDON and NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced it has been informed that John Brancaccio, Non-Executive Director, has acquired 5,000 of the Company's ordinary shares on NASDAQ at $1.61, bringing his total holding to 31,201 shares. About Urcosimod (formerly called OK-101) Urcosimod is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor which is typically found on immune cells of the eye responsible for the inflammatory response, as

    3/19/26 10:00:00 AM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABNB
    $ADV
    $ADXN
    $ALTO
    Leadership Updates

    Live Leadership Updates

    View All

    Angi Appoints Julie Hoarau to Chief Financial Officer

    DENVER, March 12, 2026 (GLOBE NEWSWIRE) -- Angi (formerly Angie's List) (NASDAQ:ANGI), a leading digital home services marketplace, today announced the appointment of Julie Hoarau as Chief Financial Officer. With more than 20 years of finance and accounting leadership experience, Ms. Hoarau will oversee the company's financial organization and help drive Angi's next phase of growth and operational performance. Ms. Hoarau will succeed Andrew "Rusty" Russakoff, who is stepping down as CFO. This transition will be effective March 27, 2026. "We are pleased to promote Julie to Chief Financial Officer," said Jeff Kip, CEO of Angi. "Julie is a trusted leader with deep financial expertise, high

    3/12/26 7:00:00 AM ET
    $ANGI
    Advertising
    Consumer Discretionary

    Coherent to Join the S&P 500

    SAXONBURG, Pa., March 09, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE:COHR) ("Coherent," "We," or the "Company"), a global leader in photonics, today announced it will join the S&P 500 index, effective Monday, March 23. Jim Anderson, CEO, said, "Joining the S&P 500 is a testament to the strength of our team, the power of our technology portfolio, and the trust our customers have placed in us. As optical interconnects and photonic solutions become foundational to scaling next-generation AI data center infrastructure, Coherent is uniquely positioned to drive innovation and deliver enhanced value to our shareholders." Regarded as the leading benchmark for U.S. large-cap equities, the S&P

    3/9/26 9:06:18 AM ET
    $COHR
    Electronic Components
    Technology

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    $ABNB
    $ADV
    $ADXN
    $ALTO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Microvast Holdings Inc.

    SC 13D/A - Microvast Holdings, Inc. (0001760689) (Subject)

    11/21/24 9:41:30 PM ET
    $MVST
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13G/A filed by Mobiquity Technologies Inc.

    SC 13G/A - Mobiquity Technologies, Inc. (0001084267) (Subject)

    11/20/24 7:44:24 PM ET
    $MOBQ
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Versus Systems Inc.

    SC 13G/A - Versus Systems Inc. (0001701963) (Subject)

    11/14/24 7:30:32 PM ET
    $VS
    EDP Services
    Technology